UroGen Pharma Ltd. Unrecognized Tax Benefits
UroGen Pharma Ltd. (URGN) had Unrecognized Tax Benefits of $1.81 million as of 2025-12-31, per its 10-K filed 2026-03-02.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefits · last filed 2026-03-02
- 2025-12-31: Unrecognized Tax Benefits $1.81M.
- 2025-09-30: Unrecognized Tax Benefits $3.80M.
- 2025-06-30: Unrecognized Tax Benefits $3.80M.
- 2025-03-31: Unrecognized Tax Benefits $3.80M.
| Period end | Unrecognized Tax Benefits | Unrecognized Tax Benefits as first filed |
|---|---|---|
| 2025-12-31 | $1.81M 10-K · filed 2026-03-02 | |
| 2025-09-30 | $3.80M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $3.80M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $3.80M 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $1.97M 10-K · filed 2026-03-02 | |
| 2024-09-30 | $3.20M 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $3.20M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $3.20M 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $1.97M 10-K · filed 2026-03-02 | $3.19M 10-K · filed 2024-03-14 |
| 2023-09-30 | $3.00M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $3.00M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $3.00M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $1.97M 10-K · filed 2025-03-10 | $3.02M 10-K · filed 2023-03-24 |
| 2022-09-30 | $2.80M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $2.80M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $2.80M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $2.84M 10-K · filed 2024-03-14 | |
| 2021-09-30 | $2.70M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $2.70M 10-Q · filed 2021-08-04 | |
| 2021-03-31 | $2.70M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $2.72M 10-K · filed 2023-03-24 | |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-09 | |
| 2019-12-31 | $0.00 10-K · filed 2022-03-21 | |
| 2017-12-31 | $0.00 20-F · filed 2018-03-15 | |
| 2016-12-31 | $0.00 20-F · filed 2018-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B |